Bortezomib-based induction therapy with high or low-dose dexamethasone in newly diagnosed, transplant-eligible multiple myeloma

  • Elias K Mai
  • Thomas Hielscher
  • Uta Bertsch
  • Jana Schlenzka
  • Hans J Salwender
  • Markus Munder
  • Christian Gerecke
  • Ulrich Dührsen
  • Peter Brossart
  • Kai Neben
  • Jens Hillengass
  • Marc S Raab
  • Maximilian Merz
  • Marc-Andrea Baertsch
  • Anna Jauch
  • Dirk Hose
  • Hans Martin
  • Hans-Walter Lindemann
  • Igor W Blau
  • Christof Scheid
  • Katja C Weisel
  • Hartmut Goldschmidt
  • German-speaking Myeloma Multicenter Group (GMMG)

Bibliographical data

Original languageEnglish
ISSN0887-6924
DOIs
Publication statusPublished - 01.2019
Externally publishedYes
PubMed 29959413